Revenue of Genmab 2008-2018

This statistic shows the annual revenue of the Danish biotechnology company Genmab from 2008 to 2018. The revenue was increasing annually from 2013 to 2018. In 2018, the revenue peaked at around three billion Danish kroner.

Revenue of Genmab from 2008 to 2018

Annual revenue in million DKK
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Denmark

Survey time period

2008 to 2018

Supplementary notes

Genmab is a Danish biotechnology company founded in 1999. The company is specializing in therapeutics for cancer treatment.

Some figures has been taken from previous publications.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Biotechnology in Germany"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.